key: cord-0851350-n8z01hnx
authors: Malek, Alexandre E.; Dagher, Hiba; Hachem, Ray; Chaftari, Anne M.; Raad, Issam I.
title: Is a single dose of mRNA vaccine sufficient for COVID‐19 survivors?
date: 2021-03-14
journal: J Med Virol
DOI: 10.1002/jmv.26915
sha: 59ca829daed35e203e77b62c93e399f2cbd63c60
doc_id: 851350
cord_uid: n8z01hnx

Amidst the evolving COVID-19 pandemic and its precarious conditions that have impacted the worldwide community, the need to achieve a herd immunity through immunization has become the only resort to control this horrendous pandemic. This article is protected by copyright. All rights reserved.

Dear Editor, Amidst the evolving COVID-19 pandemic and its precarious conditions that have impacted the worldwide community, the need to achieve herd immunity through immunization has become the only Hence, assessing the clinical benefits of mRNA vaccines in patients who recovered from COVID-19 is of utmost importance given

COVID-19 Map -Johns Hopkins Coronavirus Resource Center

FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. medRxiv

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients

Assessment of the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection in an intense reexposure setting

SARS-CoV-2 reinfection in a cohort of 43,000 antibody-positive individuals followed for up to 35 weeks. medRxiv

Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines|CDC